Stop the Increased Pain Signalling of Neuropathic Pain

Stop the Increased Pain Signalling of Neuropathic Pain

Neuropathic pain is characterised by abnormal hypersensitivity to stimuli and nociceptive responses to non-noxious stimuli as a direct consequence of a lesion or disease of the somatosensory nervous system and can result in a substantial healthcare burden and frequent comorbidities. Pregabalin is a gabapentinoid licensed for the treatment of neuropathic pain, particularly that of painful diabetic neuropathy and postherpetic neuralgia.

Modern Medicine – Issue 6 2023

Psychosis in the Drug Rehabilitation Context

Psychosis in the Drug Rehabilitation Context

Substance-induced psychosis is a loss of touch from reality triggered or induced by the use of a psychoactive substance. Often a psychotic episode is only recognised when a person presents with the hallmark or tell-tale symptoms of the disorder, which are delusions and hallucinations. Treatment interventions for substance induced psychosis broadly consist of psychotherapy, psychopharmacology and social support. Importantly, the combination of psychotherapy and psychopharmacology is more likely to improve the effectiveness of treatment outcomes.

Modern Medicine – Issue 6 2023

The Underappreciated Power of Intellectual Humility in Medicine

The Underappreciated Power of Intellectual Humility in Medicine

Intellectual humility involves recognising that there are gaps in one’s knowledge and that one’s current beliefs might be incorrect. Intellectual humility is not mere lack of confidence in one’s understanding of the world. Rather, it is the recognition that one’s understanding could be limited or wrong due to of a lack of expertise in a particular area or lack of access to relevant, accurate or complete information on the topic.

Modern Medicine – Issue 6 2023

Issue 5 2023

The latest edition of Modern Medicine is now available for you to read. We have some great articles featured in this edition:

  • Ethics (CPD) – Patient health more than just medical care
  • Cardiology – The role of beta-blockers
  • Pulmonology(CPD) – Pharmacological management of allergic rhinitis
  • Coloproctology – “Let’s talk about haemorrhoids…”
  • A RoundUp Section & many more….

Also, a reminder that, not only do we have CPD questions available within the magazine itself, we also have an online CPD portal that allows you to score even more points by simply completing your test online.

Actinic Keratosis: An Update on Management

Actinic Keratosis: An Update on Management

Actinic keratoses (AKs) are potentially premalignant cutaneous lesions that occur on chronically sunexposed regions of the body. Left untreated, a small proportion of AKs will transform into invasive squamous cell carcinomas. Treatment for AKs is broadly classified as lesion-directed therapy, and includes cryotherapy or curettage and cautery, or field treatment, which includes topical (eg 5-fluorouracil and imiquimod) and light-directed therapies. Photodynamic therapy involves application of either methyl aminolevulinate or 5-aminolevulinic acid, followed by light activation, either by red light for seven to nine minutes or continuous daylight for two hours. Ingenol mebutate is no longer considered a therapeutic option.

Modern Medicine – Issue 5 2023

Pharmacological Management of Allergic Rhinitis

Pharmacological Management of Allergic Rhinitis

The goal of allergic rhinitis (AR) management is to achieve satisfactory symptom control to ensure good quality of life. Most patients with AR are currently treated with pharmacotherapy. Inadequate treatment leads to significant reduction of quality of life that affects daily activities at home, work, and school. This is a shortened version of the original article.

Modern Medicine – Issue 5 2023

Timing of Therapy in Osteoporosis:Does it Matter?

Timing of Therapy in Osteoporosis: Does it Matter?

Osteoporosis is a common condition encountered in general practice and is significantly undertreated. Tailoring the type and timing of treatment to the individual patient is important to improve outcomes and minimise potential side effects. Bisphosphonates, denosumab and hormonal therapies are effective in decreasing hip, vertebral and nonvertebral fractures. First-line treatment selection depends on individual patient factors and preferences.

Modern Medicine – Issue 5 2023

The Role of Beta-blockers: 2023 ESH Guidelines for Managing Arterial Hypertension

The Role of Beta-blockers: 2023 ESH Guidelines for Managing Arterial Hypertension

In June, the 2023 European Society of Hypertension (ESH) Hypertension guidelines were published. Overall, the new report closely resembles its predecessor published in 2018. The guidelines confirm the preferred use of renin–angiotensin system blockers, calcium channel blockers and Thiazide/Thiazide-like diuretics, and their various combinations, for blood pressure lowering treatment. Beta-blockers (BBs) are included among the major antihypertensive medications.

Modern Medicine – Issue 5 2023

Verified by ExactMetrics